By multivariate survival analysis, E2F1 expression proved to be the most and first independent prognostic factor on overall survival of DLBCL patients (HR = 5.79, 95% CI = 2.3–14.6, and p < 0.001). This evidence concerns the gene E2F1 and diffuse large B-cell lymphoma.